A decision tree incorporating biomarkers and patient characteristics estimates mortality risk for adults with septic shock.
Implications for practice and research: Wong and colleagues' study improves on current risk stratification models for sepsis. The study's findings may lead to more homogeneous patient populations enrolled into clinical trials, increasing the chance of successful development of novel therapies for sepsis. There are no immediate practice implications, due to clinically unavailable biomarker tests and a cumbersome algorithm.